| 2024 | Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification | EUROPEAN RADIOLOGY |
| 2024 | 11C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival Prediction | CLINICAL NUCLEAR MEDICINE |
| 2024 | High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma
| YONSEI MEDICAL JOURNAL |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | The Mediating Effect of Uncertainty in Illness on Cancer Coping in Patients With Primary Malignant Brain Tumors | CANCER NURSING |
| 2023 | Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium | NEURORADIOLOGY |
| 2023 | Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study | NEUROSURGERY |
| 2023 | Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study | LANCET ONCOLOGY |
| 2023 | Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program | BRITISH JOURNAL OF CANCER |
| 2023 | Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging | JOURNAL OF NEUROSURGERY |
| 2023 | Astrocytic scar restricting glioblastoma via glutamate-MAO-B activity in glioblastoma-microglia assembloid
| Biomaterials Research |
| 2023 | What we need to know about uncertainty in illness among people with primary malignant brain tumours: A mixed-methods systematic review | JOURNAL OF CLINICAL NURSING |
| 2023 | Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
| DISCOVER ONCOLOGY |
| 2023 | Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea
| JOURNAL OF KOREAN NEUROSURGICAL SOCIETY |
| 2023 | Comparison of Single-Session, Neoadjuvant, and Adjuvant Embolization Gamma Knife Radiosurgery for Arteriovenous Malformation | NEUROSURGERY |
| 2023 | Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities
| JOURNAL OF NEURO-ONCOLOGY |
| 2023 | Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor | YONSEI MEDICAL JOURNAL |
| 2023 | Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study
| KOREAN JOURNAL OF RADIOLOGY |
| 2022 | Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | Federated learning enables big data for rare cancer boundary detection
| NATURE COMMUNICATIONS |
| 2022 | Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status | EUROPEAN RADIOLOGY |
| 2022 | Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma
| CANCERS |
| 2022 | Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
| 2022 | Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma | MOLECULAR BIOLOGY REPORTS |
| 2022 | Tissue Niche Miniature of Glioblastoma Patient Treated with Nano-Awakeners to Induce Suicide of Cancer Stem Cells | ADVANCED HEALTHCARE MATERIALS |
| 2022 | Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas
| PLOS ONE |
| 2022 | 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification | CLINICAL NUCLEAR MEDICINE |
| 2022 | Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
| CANCER CELL INTERNATIONAL |
| 2022 | Sex as a prognostic factor in adult-type diffuse gliomas: an intergrated clinical and molecular analysis according to the 2021 WHO classification | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | Pseudoprogression and peritumoral edema due to intratumoral necrosis after Gamma knife radiosurgery for meningioma
| SCIENTIFIC REPORTS |
| 2022 | A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1
| SCIENTIFIC REPORTS |
| 2022 | An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas
| RADIATION ONCOLOGY |
| 2022 | Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas | NEURORADIOLOGY |
| 2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
| 2022 | Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study
| FRONTIERS IN ONCOLOGY |
| 2022 | A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas | EUROPEAN RADIOLOGY |
| 2022 | Recent Update on Neurosurgical Management of Brain Metastasis
| Brain Tumor Research and Treatment |
| 2022 | Early-onset adverse events after stereotactic radiosurgery for jugular foramen schwannoma: a mid-term follow-up single-center review of 46 cases
| RADIATION ONCOLOGY |
| 2022 | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
| CANCER RESEARCH AND TREATMENT |
| 2022 | Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas | JOURNAL OF NEURORADIOLOGY |
| 2022 | The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11)
| CANCER RESEARCH AND TREATMENT |
| 2022 | Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2022 | Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study
| CANCER MEDICINE |
| 2022 | Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation
| KOREAN JOURNAL OF RADIOLOGY |
| 2022 | Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma | ANTICANCER RESEARCH |
| 2022 | A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
http://orcid.org/0000-0003-1509-9800
(7601549862)
